Hormones for Vasomotor Symptoms of Menopause: A Primer for the Primary Care Providers

Home
»
2025 National Conference
»
Product Details

You must select a location to proceed.

Yes

There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.

Adding Registration, Please wait...

You must be logged in to perform this action.

Cancel

Hormones for Vasomotor Symptoms of Menopause: A Primer for the Primary Care Providers

Recorded for 2025 National Conference

Credit(s):

1.03 Contact Hour(s) of CE; 0.77 of which may be applied towards Pharmacology

Program Number:

25057188

Original Program Date:

June 18, 2025

Duration:

1 hour 2 minutes

Access:

Available until July 15, 2026

Special Offer

Click here to see Special Offer(s)!

Facebook

E-Mail

Description
Sessions
Credits
Faculty
Materials
Reviews
Dates and Locations

(111)

Read Reviews

Category: 2025 National Conference, Cert Exam Domain - Assessment, Cert Exam Domain - Planning ... (show more)

Category: 2025 National Conference, Cert Exam Domain - Assessment, Cert Exam Domain - Planning, Health Promotion, OB/GYN, Recent Additions, Reproductive Health, Women's Health (show less)

Activity Duration

Content Expires:

July 15, 2026 (11:55 p.m. CT)
CE for this activity will not be available after this date.

This CE activity was recorded for the 2025 AANP National Conference.

This activity includes closed captioning.

Delivery Note: The content for this activity was previously presented during the 2025 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies.

Overview
This presentation will cover one of the most important aspects of menopause-related healthcare issues: The vasomotor symptoms (VMS) of menopause. The prevalence of menopause is about 50 million cases annually in the US, and approximately 80% of those women experience some form of vasomotor symptoms. Basic concepts such as the physiology and signs and symptoms of menopause will be briefly explained. This presentation will have a special emphasis on vasomotor symptoms among the various signs and symptoms of menopause. The assessment and plan of care for vasomotor symptoms will be discussed in detail. The pharmacological management of VMS will be examined, concentrating on the use of hormone therapy and possible contraindications for its use. The presentation will also briefly touch base on the latest developments in the treatment of VMS.

Objectives

Identify and summarize the definition, etiology, and timeline of VMS.
Examine the physiological changes and stages of menopause and correlate the signs and symptoms of menopause to the physiological changes.
Develop a plan for assessment, diagnosis, and medical management, including hormonal medications to address VMS.
Design an individualized plan of care for patients with VMS with special emphasis on hormonal agents.

Speakers
Dr. Daisy Mullassery, DrNP, APRN-CNP, WHNP-BC
Dr. Rebecca Tsusaki, PhD, APRN-CNP, WHNP-BC

Disclosure
This program was planned in accordance with AANP CE Standards and Policies.

The speakers have the following disclosures:

We have nothing to disclose.

Disclaimer
Individuals who have contributed to the CE Center (content originally from the 2025 AANP National Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

CE Credit Instructions

Read this activity description, including objectives and disclosures.
Complete all educational content:
- OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
  - A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
  - A copy of the certificate will be automatically added to your AANP CE Tracker.

Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.

1.03 Contact Hour(s) of CE,
0.77 of which may be applied towards Pharmacology